Huiwei Sun

972 total citations
24 papers, 783 citations indexed

About

Huiwei Sun is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Huiwei Sun has authored 24 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Huiwei Sun's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Mechanisms and Therapy (4 papers) and CAR-T cell therapy research (4 papers). Huiwei Sun is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Mechanisms and Therapy (4 papers) and CAR-T cell therapy research (4 papers). Huiwei Sun collaborates with scholars based in China and United States. Huiwei Sun's co-authors include Qiyu Jiang, Fan Feng, Yantao Chai, Xiaojuan Li, Yingshi Zhang, Yu Cao, Ruichuang Yang, Yongping Yang, Boan Li and Hui Jia and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochimica et Biophysica Acta (BBA) - General Subjects and Cell Death and Disease.

In The Last Decade

Huiwei Sun

24 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiwei Sun China 16 388 280 249 127 114 24 783
Şerif Şentürk Türkiye 16 796 2.1× 246 0.9× 295 1.2× 125 1.0× 82 0.7× 38 1.2k
Praveen Radhakrishnan Germany 17 377 1.0× 325 1.2× 265 1.1× 67 0.5× 44 0.4× 39 924
Yantao Chai China 11 276 0.7× 207 0.7× 160 0.6× 108 0.9× 90 0.8× 19 551
Hao‐Xiang Tan China 10 623 1.6× 426 1.5× 206 0.8× 68 0.5× 83 0.7× 12 906
Haihua Qian China 17 500 1.3× 311 1.1× 261 1.0× 46 0.4× 53 0.5× 29 828
Xiangyuan Luo China 11 391 1.0× 178 0.6× 151 0.6× 68 0.5× 66 0.6× 19 698
Gongbo Fu China 17 471 1.2× 297 1.1× 215 0.9× 237 1.9× 42 0.4× 32 927
Romain Donné France 6 267 0.7× 147 0.5× 127 0.5× 160 1.3× 39 0.3× 8 598
Guangshun Sun China 16 478 1.2× 271 1.0× 230 0.9× 58 0.5× 39 0.3× 27 790
Chi‐Hung Tzang Hong Kong 11 359 0.9× 131 0.5× 129 0.5× 152 1.2× 87 0.8× 13 718

Countries citing papers authored by Huiwei Sun

Since Specialization
Citations

This map shows the geographic impact of Huiwei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiwei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiwei Sun more than expected).

Fields of papers citing papers by Huiwei Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiwei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiwei Sun. The network helps show where Huiwei Sun may publish in the future.

Co-authorship network of co-authors of Huiwei Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Huiwei Sun. A scholar is included among the top collaborators of Huiwei Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiwei Sun. Huiwei Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jiang, Qiyu, Xue Ma, Huiwei Sun, et al.. (2024). Photosensitizing metal–organic framework nanoparticles combined with tumor-sensitization strategies can enhance the phototherapeutic effect upon medullary thyroid carcinoma. Biochimica et Biophysica Acta (BBA) - General Subjects. 1868(12). 130725–130725. 2 indexed citations
3.
4.
Liu, Xingyu, Hui Jia, Yingshi Zhang, et al.. (2022). A Novel Small-Molecule Inhibitor of SREBP-1 Based on Natural Product Monomers Upregulates the Sensitivity of Lung Squamous Cell Carcinoma Cells to Antitumor Drugs. Frontiers in Pharmacology. 13. 895744–895744. 20 indexed citations
5.
Xu, Meihong, Qiyu Jiang, Huiwei Sun, et al.. (2022). A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma. Frontiers in Pharmacology. 13. 951831–951831. 6 indexed citations
6.
Du, Fengxia, Huiwei Sun, Fang Sun, et al.. (2022). Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs. Frontiers in Pharmacology. 13. 924523–924523. 3 indexed citations
7.
He, Xi, Huiwei Sun, Qiyu Jiang, et al.. (2021). Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4. Frontiers in Oncology. 11. 735447–735447. 19 indexed citations
8.
Luo, Mei, Huiwei Sun, Qiyu Jiang, et al.. (2021). Novel Nanocrystal Injection of Insoluble Drug Anlotinib and Its Antitumor Effects on Hepatocellular Carcinoma. Frontiers in Oncology. 11. 777356–777356. 7 indexed citations
9.
Yang, Hua, Huiwei Sun, Yantao Chai, et al.. (2021). A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 783194–783194. 24 indexed citations
10.
11.
Ma, Yan, Ningli Chai, Qiyu Jiang, et al.. (2020). DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents. Pharmacological Research. 160. 105071–105071. 52 indexed citations
12.
Dai, Wenjie, Hui Jia, Yingshi Zhang, et al.. (2018). ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR. Pharmacological Research. 135. 188–200. 73 indexed citations
13.
Zhang, Yingshi, Qiyu Jiang, Shuang Cao, et al.. (2018). Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. Cell Death and Disease. 9(7). 743–743. 93 indexed citations
14.
Feng, Fan, Qiyu Jiang, Hui Jia, et al.. (2018). Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysis. Pharmacological Research. 135. 89–101. 56 indexed citations
15.
Jia, Hui, Qian Yang, Tao Wang, et al.. (2016). Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents. Biochimica et Biophysica Acta (BBA) - General Subjects. 1860(7). 1417–1430. 102 indexed citations
16.
Li, Songyan, Tingting Jia, Xiaohui Du, et al.. (2015). Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity. Tumor Biology. 36(6). 4535–4543. 32 indexed citations
17.
Feng, Fan, Xudong Gao, Chunping Wang, et al.. (2015). MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells. Current Cancer Drug Targets. 15(3). 176–187. 40 indexed citations
18.
Yang, Yan, Yingxin Xu, Yunshan Zhao, et al.. (2013). Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model. Tumor Biology. 35(2). 1113–1122. 26 indexed citations
19.
Sun, Peiming, Yingxin Xu, Xiaohui Du, et al.. (2012). An engineered three-dimensional gastric tumor culture model for evaluating the antitumor activity of immune cells in vitro. Oncology Letters. 5(2). 489–494. 15 indexed citations
20.
Du, Xiaohui, Xiangyu Wang, Ning Ning, et al.. (2012). Dynamic tracing of immune cells in an orthotopic gastric carcinoma mouse model using near-infrared fluorescence live imaging. Experimental and Therapeutic Medicine. 4(2). 221–225. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Şerif Şentürk Breakdown of academic impact, for papers by Praveen Radhakrishnan Breakdown of academic impact, for papers by Yantao Chai Breakdown of academic impact, for papers by Hao‐Xiang Tan Breakdown of academic impact, for papers by Haihua Qian Breakdown of academic impact, for papers by Xiangyuan Luo Breakdown of academic impact, for papers by Gongbo Fu Breakdown of academic impact, for papers by Romain Donné Breakdown of academic impact, for papers by Guangshun Sun Breakdown of academic impact, for papers by Chi‐Hung Tzang
Rankless by CCL
2026